Clinical Trial Update: Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT [Phase 4]

View source ↗

Summary

Phase 4 trial assessing antifungal effects of recombinant human GM-CSF in patients after allogeneic hematopoietic stem cell transplantation; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycoses

Drugs mentioned

• Leukine (sargramostim)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Mycoses | Phase 4 | Status: COMPLETED | Results posted: 2014-10-27